Thymosin beta 4 for heart attack recovery
Part of Heart & circulation clinical trials.
This study tests a new drug called thymosin beta 4 to see if it helps the heart heal better after a heart attack. You might join if you are having a specific type of heart attack and are scheduled for a procedure to open a blocked artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must be having a specific type of heart attack (called ST-elevation heart attack) or have a completely blocked main artery in your heart.
- You must be scheduled for a procedure to open the blocked artery, and it must be done within a certain time after your heart attack symptoms start.
- You must not have had a heart attack or heart procedures before.
- You must not have severe heart failure or other serious health conditions like cancer or kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a combination of antioxidant vitamins (supplements) during emergency treatment for a first heart attack can reduce heart muscle damage and improve recovery. You might be eligible if you are having an emergency angioplasty for a recent heart attack.
This trial is testing a new way to quickly measure the level of a blood thinner (tirofiban) in the blood of people having a heart attack. It aims to make sure the dose is right and safe for each patient.
This study tests an experimental cell therapy called MiSaver that may help heart muscle recover after a heart attack. It's for people whose hearts are weak and who cannot have usual procedures like stents or bypass surgery.
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Hear when a new Acute Myocardial Infarction With ST Elevation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.